Torske K E, Dyson D H, Pettifer G
Department of Clinical Studies, Ontario Veterinary College, University of Guelph.
Can Vet J. 1998 Jun;39(6):361-9.
The purpose of this study was to compare the effects of epidural bupivacaine (BUP) and oxymorphone/bupivacaine (O/B) and intravenous (i.v.) oxymorphone (IVO) on halothane requirements during hind end surgery and postoperative analgesia in 24 dogs. Dogs were randomly assigned to treatment groups: O/B--oxymorphone (0.1 mg/kg) in 0.75% bupivacaine (1 mg/kg for a total volume of 0.2 ml/kg); BUP--0.5% bupivacaine (1 mg/kg for a total volume of 0.2 ml/kg) with i.v. oxymorphone (0.05 mg/kg) postoperatively; and IVO--oxymorphone (0.05 mg/kg) pre- and postoperatively. Heart rate (HR), respiratory rate, arterial blood pressure, end-tidal carbon dioxide and halothane, and arterial blood gases were recorded prior to treatment and every 15 minutes thereafter. Once surgery had begun, end-tidal halothane concentrations were decreased as low as possible while still maintaining a stable anesthetic plane. Data were analyzed using ANOVA with P < 0.05 considered significant. End-tidal halothane requirements did not differ significantly among treatments. Respiratory depression was increased and HR was decreased in the O/B and IVO groups. Postoperative analgesic requirements were significantly less in dogs receiving O/B.
本研究的目的是比较硬膜外布比卡因(BUP)、羟吗啡酮/布比卡因(O/B)和静脉注射(i.v.)羟吗啡酮(IVO)对24只犬后肢手术期间氟烷需求量及术后镇痛的影响。将犬随机分为治疗组:O/B组——在0.75%布比卡因(1mg/kg,总体积0.2ml/kg)中加入羟吗啡酮(0.1mg/kg);BUP组——0.5%布比卡因(1mg/kg,总体积0.2ml/kg),术后静脉注射羟吗啡酮(0.05mg/kg);IVO组——术前和术后均静脉注射羟吗啡酮(0.05mg/kg)。在治疗前及之后每隔15分钟记录心率(HR)、呼吸频率、动脉血压、呼气末二氧化碳和氟烷以及动脉血气。手术开始后,呼气末氟烷浓度尽可能降低,同时仍维持稳定的麻醉平面。采用方差分析对数据进行分析,P<0.05认为具有显著性差异。各治疗组之间呼气末氟烷需求量无显著差异。O/B组和IVO组呼吸抑制加重,心率降低。接受O/B治疗的犬术后镇痛需求量显著减少。